Aberrant follicle development and anovulation in polycystic ovary syndrome (original) (raw)

Follicle dynamics and anovulation in polycystic ovary syndrome

Stephen Franks

Human Reproduction Update, 2008

View PDFchevron_right

The relationship between anti-Mullerian hormone, androgen and insulin resistance on the number of antral follicles in women with polycystic ovary syndrome

Ming-Yih Wu

Human Reproduction, 2008

View PDFchevron_right

The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest

Didier Dewailly

Human Reproduction Update, 2004

View PDFchevron_right

Μechanisms of Infertility in Polycystic Ovary Syndrome

Artemis Karkanaki

2007

View PDFchevron_right

Evidence for Abnormal Granulosa Cell Responsiveness to Follicle-Stimulating Hormone in Women with Polycystic Ovary Syndrome

Toana Kawashima

2010

View PDFchevron_right

PCOS Forum: research in polycystic ovary syndrome today and tomorrow

Elisabet Stener-Victorin, K. Hoeger, Roy Homburg

Clinical Endocrinology, 2011

View PDFchevron_right

Alterations of folliculogenesis in women with polycystic ovary syndrome

Valeria Sander

The Journal of Steroid Biochemistry and Molecular Biology, 2011

View PDFchevron_right

The diagnosis and the reproductive and metabolic consequences of polycystic ovary syndrome

Mohannad Abu Faza

Journal of Obstetrics and Gynecological Investigations, 2018

View PDFchevron_right

Changes in Serum Anti-Müllerian Hormone Level during Low-Dose Recombinant Follicular-Stimulating Hormone Therapy for Anovulation in Polycystic Ovary Syndrome

C. Decanter

The Journal of Clinical Endocrinology & Metabolism, 2007

View PDFchevron_right

Development of morphologically dominant follicles is associated with fewer metabolic disturbances in amenorrheic women with polycystic ovary syndrome: a pilot study

Anna Kepley

2010

View PDFchevron_right

Why does ovarian surgery in PCOS help? Insight into the endocrine implications of ovarian surgery for ovulation induction in polycystic ovary syndrome

Roy Homburg, Matthijs Hendriks

Human Reproduction Update, 2007

View PDFchevron_right

Androstenedione response to recombinant human FSH is the most valid predictor of the number of selected follicles in polycystic ovarian syndrome: (a case-control study)

Eser Ozyurek

Journal of Ovarian Research

View PDFchevron_right

Impact of Polycystic Ovary Syndrome, Metabolic Syndrome, Obesity, and Follicular Growth Arrest in Women Health

Soledad Henríquez

ISGE Series

View PDFchevron_right

Characterization of Intrafollicular Steroid Hormones, Inhibin, and Follistatin in Women with and without Polycystic Ovarian Syndrome Following Gonadotropin Hyperstimulation1

Keith Isaacson

Biology of Reproduction, 1997

View PDFchevron_right

Polycystic Ovary Syndrome: Pathogenesis, Treatment and Secondary Associated Diseases

Sachin Goyal

Journal of Drug Delivery and Therapeutics

View PDFchevron_right

Characterization of intrafollicular steroid hormones, inhibin, and follistatin in women with and without polycystic ovarian syndrome following gonadotropin hyperstimulation

Geralyn Messerlian

Biology of Reproduction, 1997

View PDFchevron_right

Interface between Extra‐ and Intraovarian Factors in Polycystic Ovarian Syndrome

Arlene Morales

Annals of the New York Academy of Sciences, 1993

View PDFchevron_right

Interactions between androgens, FSH, anti-Müllerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary

maeliss peigne

Human Reproduction Update, 2016

View PDFchevron_right

Hormonal Parameters in Diverse Phenotypes of Polycystic Ovarian Syndrome

Farhana Sharmin, Mohammad K Khan

MMJ, 2023

View PDFchevron_right

The role of intraovarian regulators in the aetiology of polycystic ovarian syndrome

Alan Trounson

Reproductive Medicine Review, 1996

View PDFchevron_right

Low-dose FSH therapy for anovulatory infertility associated with polycystic ovary syndrome: rational, results, reflections refinements

Colin Howles

1999

View PDFchevron_right

Folliculogenesis Disturbances within the Polycystic Ovarian Syndrome and Possible Consequences on Oocyte Quality

Mihai Surcel

Acta Endocrinologica, 2012

View PDFchevron_right

Polycystic Ovary Syndrome (PCOS) and Fertility

Guilherme Barbosa

Open Journal of Endocrine and Metabolic Diseases, 2016

View PDFchevron_right

Predictive Value of Follicular Stimulating Hormone on Luteinizing Hormone Ratio for Ovarian Response to Simple Ovulation Induction in Patients with Polycystic Ovarian Syndrome

Mohamed Fathy Abohashim

The Egyptian Journal of Hospital Medicine

View PDFchevron_right

Polycystic ovary syndrome: pathogenetic mechanisms of the disease (part 1)

Moamar AL-JEFOUT

Siberian Medical Review

View PDFchevron_right

Cohort Size Rather Than Follicle-Stimulating Hormone Threshold Level Determines Ovarian Sensitivity in Polycystic Ovary Syndrome 1

Joop Schoemaker

The Journal of Clinical Endocrinology & Metabolism, 1998

View PDFchevron_right

Endocrine Disturbances in Polycy'stic Ovary Sy'ndrome

Aydin Ahmed

Tikrit Journal of Pharmaceutical Sciences

View PDFchevron_right

The central role of ovulatory disturbances in the etiology of androgenic polycystic ovary syndrome (PCOS)—Evidence for treatment with cyclic progesterone

Sonia Shirin

Drug Discovery Today: Disease Models, 2020

View PDFchevron_right

Polycystic Ovarian Morphology with Regular Ovulatory Cycles: Insights into the Pathophysiology of Polycystic Ovarian Syndrome

Ann Taylor

The Journal of Clinical Endocrinology & Metabolism, 2004

View PDFchevron_right

Anti-mullerian hormone and antral follicle count in polycystic ovary syndrome and non-polycystic ovary syndrome women

Shahla Alalaf

Zanco Journal of Medical Sciences, 2018

View PDFchevron_right

Ovulation After Glucocorticoid Suppression of Adrenal Androgens in the Polycystic Ovary Syndrome Is Not Predicted by the Basal Dehydroepiandrosterone Sulfate Level 1

Gene Hines

The Journal of Clinical Endocrinology & Metabolism, 1999

View PDFchevron_right

The Polycystic Ovary Syndrome: an Endocrinological Perspective from the European Society of Endocrinology

R. Pasquali, Didier Dewailly, Michel Pugeat

2014

View PDFchevron_right